BH-011

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameBH-011
Drug Alias Name膀胱灌注给药的多西他赛（贝海生物）Docetaxel （Beihai）BH011（多西他赛注射液（不含吐温80型））BH011（多西他赛注射液（膀胱灌注给药且不含吐温80））BH-011 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhuhai Beihai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhuhai Beihai Biotechnology Co Ltd
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A